Every story in this section, newest first — page 339 of 373.
Shares of software supply chain platform JFrog (NASDAQ:FROG) fell 4.7% in morning trading on January 8, 2026, as part of a broader market rotation out of the technology sector.
The decline came amid profit-taking in high-growth tech stocks following a strong recent rally, particularly in artificial-intelligence-related names.
Acrivon Therapeutics (NASDAQ:ACRV) unveiled promising interim data from its lead oncology program on Thursday, demonstrating that its biomarker-driven approach can achieve significant results in patients with hard-to-treat serous endometrial cancer.
The company’s lead candidate, ACR-368, a selective CHK1/2 inhibitor, showed a 67% confirmed objective response rate (cORR) in a subset of patients identified by Acrivon’s proprietary "OncoSignature" biomarker.
Paramount (NASDAQ:PSKY) reaffirmed its $30-per-share cash offer for Warner Bros. Discovery on Thursday, resisting pressure to sweeten the deal even after WBD’s board dismissed the proposal as a risky "leveraged buyout."
Viking Therapeutics (NASDAQ:VKTX) finished enrolling patients in a clinical trial designed to test how different dosing schedules of its experimental obesity drug can help people keep weight off, a key step in its bid to compete with established giants in the metabolic space.
Northern Technologies International Corporation (NASDAQ:NTIC) reported consolidated net sales of $23.309 million for its fiscal first quarter of 2026, a 9.2% increase from the prior-year period and marking a new quarterly record.
Eupraxia Pharmaceuticals (NASDAQ:EPRX) reported positive interim data from its ongoing Phase 1b/2a RESOLVE trial evaluating EP-104GI in patients with eosinophilic esophagitis.
RPM International (NYSE:RPM), a world leader in specialty coatings, sealants and building materials, reported record fiscal second-quarter sales of $1.91 billion for the period ended November 30, 2025, representing a 3.5% increase over the prior-year record.
Watertown, Massachusetts-based Acrivon Therapeutics (NASDAQ:ACRV) provided an interim clinical update across its precision oncology pipeline, highlighted by promising response rates for its lead candidate ACR-368 in an ongoing Phase 2b trial.
Invivyd (NASDAQ:IVVD) reported preliminary fourth-quarter net product revenue of $17.2 million for its COVID-19 antibody, PEMGARDA.
The figure marks a 25% increase over the same period last year and a 31% sequential jump from the third quarter.
Simply Good Foods (NASDAQ:SMPL) reported a 33.7% drop in net income to $25.3 million for the first quarter ended Nov. 29, 2025.
The Denver-based company was hit by a significant contraction in gross margins, which fell 590 basis points to 32.3%.
Lindsay Corporation (NYSE:LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today reported its financial results for the first quarter of fiscal 2026, ended November 30, 2025.
Helen of Troy Limited (NASDAQ:HELE) reported third-quarter fiscal 2026 results that reflected ongoing headwinds in the consumer discretionary sector.
Commercial Metals Company (NYSE:CMC) reported solid financial performance for its fiscal first quarter of 2026, ended November 30, 2025, with net earnings of $177.3 million, or $1.58 per diluted share.
China is preparing to approve the import of Nvidia Corp.’s (NASDAQ:NVDA) H200 artificial intelligence chips for select commercial customers as soon as this quarter, according to people familiar with the matter.
NervGen Pharma Corp. (NASDAQ:NGEN) officially began trading on the Nasdaq Stock Market on January 8, marking a transition into a late-stage biopharmaceutical player.
Energy Fuels (NYSE:UUUU) released an updated Feasibility Study on Thursday for its 100%-owned heavy mineral sands project in Madagascar, signaling a major step toward transforming the company into a diversified critical minerals powerhouse.
Ceragon Networks (NASDAQ:CRNT) signaled a temporary shift in its 2025 finish line, projecting fourth-quarter revenue between $81 million and $83 million.
Acuity (NYSE:AYI) reported a strong start to fiscal 2026, with first-quarter net sales climbing 20.2% to $1.1 billion.
European Union antitrust enforcers will decide by February 10 whether to approve Alphabet's (NASDAQ:GOOGL) $32 billion acquisition of cybersecurity startup Wiz.
The Competition Commission of India (CCI) told the Delhi High Court that calculating antitrust fines based on a company’s global turnover is essential to prevent multinational corporations from treating penalties as a "nominal" cost of doing business.
China will conduct a formal assessment and investigation into Meta Platforms (NASDAQ:META) acquisition of artificial intelligence startup Manus, the Chinese Ministry of Commerce (MOFCOM) announced Thursday.
Vornado Realty Trust (NYSE:VNO) has finalized the acquisition of 3 East 54th Street, a strategic Manhattan development site, for $141 million.
The deal, completed on January 7, effectively converts a distressed debt position into a fee-simple ownership of 18,400 square feet of prime Plaza District land.
Boyd Group Services (NYSE:BGSI) announced it has received all necessary regulatory clearances to finalize its acquisition of Joe Hudson’s Collision Center (JHCC), with the transaction scheduled to close on January 9, 2026.
Organon (NYSE:OGN) has entered a strategic agreement with Daiichi Sankyo Europe to commercialize Nilemdo® (bempedoic acid), a first-in-class treatment for high cholesterol, across France, Denmark, Iceland, Sweden, Finland, and Norway.
